Terns Pharmaceuticals surges on Merck’s reported $6 billion takeover bid as Keytruda patent clock ticks
NEW YORK, March 25, 2026 — Terns Pharmaceuticals (NASDAQ: TERN) is the sharpest...
NEW YORK, March 25, 2026 — Terns Pharmaceuticals (NASDAQ: TERN) is the sharpest...